Elevated in vivo expression of the costimulatory molecule B7-BB1 (CD80) on antigen presenting cells from a patient with SLE

Clinical and Experimental Rheumatology

Volumn 14, Issue 6, 1996, Pages 695-697

  Kovacs, B ^a   Thomas, D E ^b   Tsokos, G C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

activation; antigen presenting cells; costimulation; SLE

Indexed keywords

B7 ANTIGEN; METHYLPREDNISOLONE; PREDNISONE;

ANTIGEN PRESENTING CELL; ARTICLE; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANTI-INFLAMMATORY AGENTS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; CHILD; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INTERFERON TYPE II; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISOLONE;

EID: 0030455480     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. TSOKOS GC: Overview of cellular immune function in systemic lupus erythematosus. In: LAHITA RG (Ed.): Systemic Lupus Erythematosus. New York, Churchill Livingstone, 1992: 15-50.
2. JUNE CH, BLUESTONE JA, NADLER LM, THOMPSON CB: The B7 and CD28 receptor families. Immunol Today 1994; 15: 321-31.
3. KOULOVA L, CLARK EA, SHU G, DUPONT B: The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J Exp Med 1991; 173: 759-62.
4. LINSLEY PS, BRADY W, GROSMAIRE L, ARUFFO A, DAMLE NK, LEDBETTER JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991; 173: 721-30.
5. GIMMI CD, FREEMAN GJ, GRIBBEN JG, GRAY G, NADLER LM: Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90: 6586-90.
6. FINCK BK, LINSLEY PS, WOFSY D: Treatment of murine lupus with CTLA4Ig. Science 1994; 265: 1225-7.
7. TSOKOS GC, KOVACS B, SFIKAKIS PP, THEOCHARIS S, VOGELGESANG S, VIA CS: Defective antigen-presenting cell function in patients with systemic lupus erythematosus. Role for the B7-1 (CD80) costimulatory molecule. Arthritis Rheum 1996; 39: 600-9.
8. FREEDMAN AS, FREEMAN G, RYHNHART K, NADLER LM: Selective induction of B7/BB1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 1991; 137: 429-37.
9. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D. CHANG CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
10. RANHEIM EA, KIPPS TJ: Elevated expression of CD80 (B7/ BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. Arthritis Rheum 1994; 37: 1637-46.
11. VERWILGHEN J, LOVIS R, DE BOER M, LINSLEY PS, HAINES GK, KOCH AE, POPE RM: Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J Immunol 1994; 153: 1378-85.